AstraZeneca Pharma India Limited Sustainability Profile
AstraZeneca Pharma India Limited, a subsidiary of the global biopharmaceutical giant AstraZeneca, is headquartered in India and operates extensively across the country. Founded in 1979, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular, renal, and respiratory diseases. With a commitment to research and development, AstraZeneca India has introduced a range of unique products that address unmet medical needs, enhancing patient outcomes. The company is recognised for its strong market position, driven by a robust pipeline and strategic partnerships. Notable achievements include significant contributions to the healthcare landscape in India, underscoring its role in advancing medical science and improving public health.
DitchCarbon Score
How does AstraZeneca Pharma India Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AstraZeneca Pharma India Limited's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AstraZeneca Pharma India Limited's reported carbon emissions
In 2024, AstraZeneca Pharma India Limited reported carbon emissions of approximately 452,000 kg CO2e, a reduction from about 618,000 kg CO2e in 2023. These figures represent Scope 1 emissions, which are direct emissions from owned or controlled sources. The company has not disclosed any Scope 2 or Scope 3 emissions data. Despite the significant reduction in emissions, AstraZeneca Pharma India Limited does not currently have specific reduction targets or initiatives outlined in their climate commitments. However, as a current subsidiary of AstraZeneca PLC, the company may align with broader corporate sustainability goals and initiatives cascaded from its parent organisation. AstraZeneca PLC has been involved in various climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which may influence AstraZeneca Pharma India Limited's future climate strategies. The company is committed to enhancing its sustainability practices, although specific targets or pledges have not been detailed at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 618,000 | 000,000 |
| Scope 2 | - | - |
| Scope 3 | - | - |
How Carbon Intensive is AstraZeneca Pharma India Limited's Industry?
How Carbon Intensive is AstraZeneca Pharma India Limited's Location?
AstraZeneca Pharma India Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AstraZeneca Pharma India Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
